Public Citizen's Global Access to Medicines Program works with partners worldwide to improve health outcomes and save lives, through use of pharmaceutical cost-lowering measures including generic competition.
We help civil society groups and public agencies overcome patent-based and other drug monopolies. We assess new developments in policy and law, and work with coalition partners to promote game-changing ideas that advance pharmaceutical access and innovation simultaneously. Our work challenges Big Pharma's economic and political power. Among other priorities, we advocate for:
- more extensive global use of compulsory licenses (legal grants of authority to use third parties' patented inventions),
- expanded licensing of U.S. government-funded technology,
- vastly improved terms for access to medicines in trade agreements, including the proposed Trans-Pacific Partnership trade agreement, and
- rational, regulatory-based policies to ensure medicines quality and pharmaceutical industry accountability.
More Information on Access to Medicine
- Leaked Cables Show U.S. Tried, Failed to Organize Against Ecuador Compulsory Licensing, May 10, 2011
- Trans-Pacific FTA Agreement: Leaked Intellectual Property Proposals - New Zealand: Proposed IP Chapter Text, February 23, 2011
- Trans-Pacific FTA Agreement: Leaked Intellectual Property Proposals - Chile: Preliminary Considerations for TPP IP Chapter, February 23, 2011
- Trans-Pacific FTA: Leaked Intellectual Property Proposals: United States: Jane Kelsey, "New Leaks of TPPA Text Show U.S. is Playing Hardball", February 17, 2011
- U.S. TPP Partial IPR Text Goes Beyond Old FTA Provisions On Copyrights, February 17, 2011
- Letter from Trans-Pacific FTA Member Countries Health Groups to Trade Ministers on Safeguarding Access to Medicines in the Trans-Pacific Partnership Agreement (En Espanol), February 15, 2011
- Why the Trans Pacific Partnership Should Not Include Pharmaceutical Pricing Provisions, Program on Information Justice and Intellectual Property (PIJIP) at American University Washington College of Law, December 4, 2010
- Memo on Trans-Pacific FTA Negotiations and Access to Medicines, December 4, 2010
- Press Release: Leaked New Zealand Paper Challenges U.S. FTA Models in Trans-Pacific Trade Negotiations; Access to Medicines at Stake, December 4, 2010
- Analysis of the Leaked New Zealand Paper on IP and TPP, Public Citizen and Third World Network, December 3, 2010
- Leaked New Zealand Paper on Intellectual Property and the Proposed Trans-Pacific FTA, Posted December 3, 2010
- Comments on USPTO Proposal for Incentivizing Humanitarian Licensing of Patented Technologies, joint submission with Medicins Sans Frontieres, Oxfam America and Knowledge Ecology International, November 19, 2010
- One Year of the Peru-U.S. FTA: Study results in Spanish, Peruvian Network for Globalization with Equity (RedGE), September 2010
- ACTA and Public Health (links to digitalcommons.wcl.american.edu), September 2010
- ACTA's Scope and Access to Medicines, September 10, 2010
- Coalition Letter on the Proposed Trans Pacific FTA and Global Access to Medicines, September 9, 2010
- Comments to the European Commission on Customs Regulation 1383/2003, May 25, 2010
- Press Release: By Authorizing Generic Competition, Ecuador Cuts Cost of Key HIV/AIDS Drug, April 22, 2010
No comments:
Post a Comment